Kevin Quon
Insider ownership, small-cap, long-term horizon, dividend investing

Intermolecular, Inc: Disrupting A Model Of Innovation

Technology capable of disrupting an industry is often hard to find as an investor. Yet the reward of significant investment returns often lie in the identification of such opportunities prior to them becoming common knowledge. It is for this reason that I want to highlight a small company that has brought together a proprietary process that significantly evolves the field of research & development [R&D].

With a small market capitalization of $332 million, it may be easy to dismiss Intermolecular, Inc. (IMI). Yet to do so, would neglect the advancement of a new business model capable of introducing rapid accelerations to an inefficient and laborious process of R&D. The company maintains a proprietary process that streamlines the...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
FREESA PRO MEMBERS
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details